TMO

Thermo Fisher Scientific Inc

$504.04

8.99 (1.75%) Today

— up— down

Compare TMO

Market Cap

$190.65B+23.4%

Revenue (TTM)

$45.03B+5.4%

Net Income (TTM)

$6.75B+6.7%

EPS (TTM)

18.17+6.7%

Shares Out

371.62M

P/E Ratio

27.28

Forward P/E

18.06

Dividend

$1.68 (0.37%)

Ex-Dividend Date

Jun 15, 2026

Open

$511.67

Previous Close

$513.03

Day Range

$501.44 – $510.95

52-Week Range

$401.45 – $643.99

Beta

0.84

Volume

1.06M

Avg Volume

2.22M

Analyst Rating

Buy

Exchange

NEW YORK STOCK EXCHANGE, INC.

About TMO

Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).

A vs